| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 70,317 | 64,667 | 65,158 | 68,337 | | Cost of Revenue | 21,353 | 20,794 | 21,748 | 24,475 | | | Gross Profit | 48,964 | 43,873 | 43,410 | 43,862 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 15,763 | 5,820 | 5,935 | 5,099 | | Non Recurring |
-
| 5,200 |
-
|
-
| | Others | 20,213 | 19,652 | 20,397 | 16,733 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 12,988 | 13,201 | 17,078 | 22,030 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 10,467 | 31,497 |
-
| | Earnings Before Interest And Taxes | 11,466 | 15,620 | 47,678 | 18,511 | | Interest Expense | 8,692 | 9,564 | 11,210 | 10,252 | | Income Before Tax | 2,774 | 6,056 | 36,468 | 8,259 | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest | (407) | (7,531) |
-
| (1,577) | | | | Net Income From Continuing Ops | 3,957 | 6,056 | 36,468 | 9,505 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,957 | 6,056 | 36,468 | 9,505 | | Preferred Stock And Other Adjustments |
-
| 5,698 | (5,698) | (1,406) | | | Net Income Applicable To Common Shares | $3,957 | $11,754 | $30,770 | $8,099 |
|
0.83% Nasdaq 
Income Statement
